PROTEASE AND PLASMINOGEN-ACTIVATOR ACTIVITY IN HUMAN BLADDER-CARCINOMA

被引:8
作者
GORELIK, U
LINDNER, A
MAYER, M
机构
[1] HADASSAH UNIV HOSP,HADASSAH MED CTR,DEPT CLIN BIOCHEM,POB 12000,IL-91120 JERUSALEM,ISRAEL
[2] WOLFSOHN HOSP,DEPT UROL,HOLON,ISRAEL
来源
BRITISH JOURNAL OF UROLOGY | 1990年 / 66卷 / 02期
关键词
D O I
10.1111/j.1464-410X.1990.tb14897.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Summary The ability of human bladder tissue extracts to cleave 14C‐labelled globin in the absence and in the presence of plasminogen was assayed to quantify non‐specific protease and plasminogen activator (PA) activity, respectively. In normal human bladder tissue the non‐specific protease activity was approximately 2‐fold higher than in tissue samples obtained from transitional cell carcinoma of the bladder (TCC). In contrast, PA activity was almost 4‐fold higher in TCC than in normal transition cell epithelium. Acid‐treated urine from 19 patients with TCC of the bladder exhibited significantly higher levels of plasminogen activator activity than similarly treated urine from controls. These results indicate that malignant transformation of the bladder epithelial tissue results in elevated levels of PA in the tissue and in urine. Further studies are needed to assess the potential of PA determination in the management of bladder cancer patients. © 1990 British Journal of Urology
引用
收藏
页码:170 / 174
页数:5
相关论文
共 23 条
[1]  
ASTRUP T, 1978, PROGR CHEM FIBRINOLY, V3, P1
[2]  
COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77
[3]  
DANO K, 1989, CANCER METASTASIS MO, P88
[4]  
DANO K, 1985, ADV CANCER RES, V44, P140
[5]  
DANO K, 1988, TISSUE TYPE PLASMINO, P19
[6]  
FINCI Z, 1986, EXP HEMATOL, V14, P293
[7]   STUDY ON FIBRINOLYSIS IN EXPERIMENTAL BLADDER TUMORS [J].
HISAZUMI, H ;
FUKUSHIMA, K .
UROLOGICAL RESEARCH, 1973, 1 (04) :186-191
[8]  
HISAZUMI H, 1973, INVEST UROL, V11, P28
[9]  
HISAZUMI H, 1977, UROL RES, V5, P133
[10]  
Hisazumi H, 1974, Urol Res, V2, P137